| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 活血止痛膏(元) | 125,576,702.02 | 208,702,996.97 | 123,630,141.17 | 262,352,414.82 | 109,282,120.17 |
| 基因工程药(元) | 949,855,382.23 | 1,803,959,085.33 | 881,828,803.98 | 2,032,058,873.14 | 904,614,923.47 |
| 其他(元) | - | 523,380,699.38 | - | 571,340,771.99 | - |
| 营业成本(元) | |||||
| 活血止痛膏(元) | 17,742,725.84 | 35,761,649.37 | 21,109,755.17 | 36,266,248.37 | 19,310,451.84 |
| 基因工程药(元) | 160,166,964.67 | 267,435,135.49 | 121,602,725.63 | 282,943,866.10 | 122,532,367.61 |
| 其他(元) | - | 270,111,888.53 | - | 301,134,067.16 | - |
| 毛利(元) | |||||
| 活血止痛膏(元) | 107,833,976.18 | 172,941,347.60 | 102,520,386.00 | 226,086,166.45 | 89,971,668.33 |
| 基因工程药(元) | 789,688,417.56 | 1,536,523,949.84 | 760,226,078.35 | 1,749,115,007.04 | 782,082,555.86 |
| 其他(元) | - | 253,268,810.85 | - | 270,206,704.83 | - |
| 毛利率(%) | |||||
| 活血止痛膏(%) | 85.87 | 82.86 | 82.93 | 86.18 | 82.33 |
| 基因工程药(%) | 83.14 | 85.18 | 86.21 | 86.08 | 86.45 |
| 其他(%) | - | 48.39 | - | 47.29 | - |
| 收入构成(%) | |||||
| 活血止痛膏(%) | 11.68 | 8.23 | 12.30 | 9.15 | 10.78 |
| 基因工程药(%) | 88.32 | 71.13 | 87.70 | 70.91 | 89.22 |
| 其他(%) | - | 20.64 | - | 19.94 | - |
| 毛利构成(%) | |||||
| 活血止痛膏(%) | 12.01 | 8.81 | 11.88 | 10.07 | 10.32 |
| 基因工程药(%) | 87.99 | 78.28 | 88.12 | 77.90 | 89.68 |
| 其他(%) | - | 12.90 | - | 12.03 | - |